Indiana Daily Student

FDA authorizes Moderna, Johnson & Johnson boosters, allows ‘mix and match’

<p></p>

The U.S. Food and Drug Administration authorized Moderna and Johnson & Johnson booster shots for some vulnerable populations Wednesday, increasing the number of vaccine options available for Americans.

The Moderna booster shot is authorized for individuals 65 and older and high-risk 18 to 64 year olds at least six months after completion of a primary series, according to the release. The J&J booster is authorized for individuals 18 or older at least two months after their first J&J shot.

The FDA is also permitting a mix-and-match option among Pfizer, Moderna and J&J boosters, allowing medical providers to offer Americans boosters different from the vaccination shots they initially received.

An advisory panel to the Centers for Disease Control and Prevention unanimously recommended the use of booster shots for many recipients of the Moderna and J&J vaccines Thursday, according to the New York Times. The panel also endorsed the “mix-and-match” strategy allowed by the FDA.

The COVID-19 vaccination is required for all IU students, faculty and staff, unless they have a medical, religious or ethical exemption or are enrolled in a 100% online program, according to IU's COVID-19 policy. Individuals can report their vaccination status or request an exemption using IU’s online vaccine reporting form.

Like what you're reading?

Stay on top of the COVID-19 and vaccination news. This weekly newsletter will package our coverage of cornavirus news, updates and the critical information you need to know.

Signup today!
Like what you're reading? Support independent, award-winning college journalism on this site. Donate here.

Comments


Powered by Solutions by The State News
All Content © 2021 Indiana Daily Student